CVS Health Corporation $CVS Shares Sold by Bleakley Financial Group LLC

Bleakley Financial Group LLC lessened its holdings in shares of CVS Health Corporation (NYSE:CVS) by 46.4% in the second quarter, according to its most recent filing with the SEC. The firm owned 26,765 shares of the pharmacy operator’s stock after selling 23,150 shares during the quarter. Bleakley Financial Group LLC’s holdings in CVS Health were worth $1,846,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in CVS. GAMMA Investing LLC boosted its position in CVS Health by 198.5% during the 1st quarter. GAMMA Investing LLC now owns 18,669 shares of the pharmacy operator’s stock worth $1,265,000 after acquiring an additional 12,415 shares during the period. Golden State Wealth Management LLC lifted its holdings in shares of CVS Health by 5,096.1% in the first quarter. Golden State Wealth Management LLC now owns 3,949 shares of the pharmacy operator’s stock valued at $268,000 after buying an additional 3,873 shares during the period. Pure Financial Advisors LLC acquired a new stake in shares of CVS Health in the first quarter valued at $204,000. Sequoia Financial Advisors LLC lifted its holdings in shares of CVS Health by 9.1% in the first quarter. Sequoia Financial Advisors LLC now owns 44,905 shares of the pharmacy operator’s stock valued at $3,042,000 after buying an additional 3,748 shares during the period. Finally, Robeco Institutional Asset Management B.V. lifted its holdings in shares of CVS Health by 33.8% in the first quarter. Robeco Institutional Asset Management B.V. now owns 290,990 shares of the pharmacy operator’s stock valued at $19,715,000 after buying an additional 73,583 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CVS. Jefferies Financial Group upped their price objective on CVS Health from $80.00 to $92.00 in a report on Wednesday, October 15th. Barclays upped their price objective on CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Wells Fargo & Company upped their price objective on CVS Health from $84.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Leerink Partners upped their price objective on CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 16th. Finally, Wall Street Zen raised CVS Health from a “hold” rating to a “buy” rating in a report on Sunday, September 21st. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.38.

CVS Health Stock Up 1.1%

Shares of NYSE:CVS opened at $81.95 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The company has a market cap of $103.94 billion, a PE ratio of 22.89, a price-to-earnings-growth ratio of 0.89 and a beta of 0.60. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $83.52. The firm has a 50 day simple moving average of $75.57 and a 200 day simple moving average of $68.67.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio is currently 74.30%.

Insider Transactions at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.22% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.